• 1
    Marti GE, Faguet G, Bertin P, Agee J, Washington G, Ruiz S, Carter P, Zenger V, Vogt R, Noguchi P. CD20 and CD5 expression in B-chronic lymphocytic leukemia. Ann N Y Acad Sci 1992; 651: 480483.
  • 2
    Almasri NM, Duque RE, Iturraspe J, Everett E, Braylan RC. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Am J Hematol 1992; 40: 259263.
  • 3
    Cinaldi L, De Martinis M, Matutes E, Farahat N, Morilla R, Catovsky D. Levels of expression of CD19 and CD20 in chronic B cell leukaemias. J Clin Pathol 1998; 51: 364369.
  • 4
    D'Arena G, Musto P, Cascavilla N, Dell'Olio M, Di Renzo N, Carotenuto M. Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders. Am J Hematol 2000; 64: 275281.
  • 5
    Byrd JC, Murphy T, Howard RS, Lucas MS, Goodrich A, Park K, Pearson M, Waselenko JK, Ling G, Grever MR, Grillo-Lopez AJ, Rosenberg J, Kunkel L, Flinn IW. Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity. J Clin Oncol 2002; 19: 21532164.
  • 6
    Bikoue A, George F, Poncelet P, Mutin M, Janossy G, Sampol J. Quantitative analysis of leukocyte membrane antigen expression: Normal adult values. Cytometry 1996; 26: 137147.
  • 7
    Denny TN, Stein D, Mui T, Scolpino A, Holland B. Quantitative determination of surface antibody binding capacities of immune subsets present in peripheral blood of healthy adult donors. Cytometry 1996; 26: 265274.
  • 8
    Davis KD, Abrams B, Iyer SB, Hoffman RA, Bishop JE. Determination of CD4 antigen density on cells: Role of antibody valency, avidity, clones, and conjugation. Cytometry 1998; 33: 197205.
  • 9
    Hildebrandt M, Paulus M, Serke S. Immunomagnetic selection of CD34-positive cells with simultaneous depletion of CD4-positive cells using the Isolex® system. Bone Marrow Transplant 1998; 21.
  • 10
    Wang L, Gaigalas AK, Abbasi F, Marti GE, Vogt RF, Schwartz A. Quantitating fluorescence intensity from fluorophores: Practical use of MESF values. J Res Natl Inst Stand Technol 2002; 107: 339353.
  • 11
    Microspheres with immobilized fluorescein isothiocyanate. National Institute of Science and Technology. Gaithersburg, Maryland, 2004. Report of Investigation of RM 8640.
  • 12
    Gaigalas AK, Wang L, Schwartz A, Marti GE, Vogt RF. Quantitating fluorescence intensity from fluorophore: Assignment of MESF values. J Res Natl Inst Stand Technol 2005; 110: 101114.
  • 13
    Ritchie AWS, Gray RA, Micklem HS. Right angle light scatter: A necessary parameter in flow cytofluorimetric analysis of human peripheral blood mononuclear cells. J Immunol Methods 1983; 64: 109117.
  • 14
    Renzi P, Ginns LC. Analysis of T-cell subsets in normal adults-comparison of whole-blood lysis technique to Ficoll-Hypaque separation by flow-cytometry. J Immunol Methods 1987; 98: 5356.
  • 15
    Quantitative fluorescence cytometry: An emerging consensus. Cytometry 1998; 33: 93287.
  • 16
    Poncelet P, Poinas G, Corbeau P, Devaux C, Tubiana N, Muloko N, Tamalet C, Chermann JC, Kourilsky F, Sampol J. Surface CD4 density remains constant on lymphocytes of HIV-infected patients in the progression of disease. Res Immunol 1991; 142: 291298.
  • 17
    Gratama JW, D'hautcourt J-L, Mandy F, Rothe G, Barnett D, Janossy G, Papa S, Schmitz G, Lenkei R. Flow cytometric quantitation of immunofluorescence intensity: Problems and perspectives. Cytometry 1998; 33: 166178.